Abstract:Mutations in the BRCA1 or BRCA2 genes predispose to a wide spectrum of familial cancers. The functions of the proteins encoded by BRCA1 and BRCA2 remain to be elucidated, but their interaction and colocalization with hRAD51 suggest a role in homologous recombination and DNA double-strand break (DSB) repair. The role of BRCA1 and BRCA2 in the rejoining of ionizing radiation (IR)-induced DNA DSBs, which may represent a step in the overall process of repair, remains uncertain because recent reports provide conflicting results. Because elucidation of the role of these proteins in DNA DSB rejoining is important for their functional characterization, we reexamined this end point in cells with mutations in either BRCA1 or BRCA2. We show that two pancreatic carcinoma cell lines known to have either wild-type (BxPC3) or mutant forms (Capan-1) of BRCA2 rejoin IR-induced DNA DSBs to a similar extent following biphasic kinetics characterized by a fast and a slow component. Importantly, inactivation of DNA-dependent protein kinase (DNA-PK) by wortmannin generates similar shifts from the fast to the slow component of rejoining in BRCA2-proficient and BRCA2-deficient cells. This suggests that the functioning of either the fast, DNA-PK-dependent component or the slow, DNA-PK-independent component of rejoining is not affected by mutations in BRCA2. Also, a human breast cancer cell line with mutated BRCA1 shows normal rejoining of IR-induced DNA DSBs and levels of inhibition by wortmannin commensurate with the degree of DNA-PK inhibition. These observations fail to confirm a direct role for BRCA1 or BRCA2 in the rejoining of IR-induced DSBs in the genome of human tumor cells and, as a result, an involvement in nonhomologous end-joining. They are in line with similar observations with mutants deficient in genes implicated in homologous recombination and support the view that the radiosensitivity to killing of cells deficient in BRCA1 or BRCA2 derives from defects in this repair pathway.

Differences in 53BP1 and BRCA1 regulation between cycling and non-cycling cells

Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1.

RAP80-directed Tuning of BRCA1 Homologous Recombination Function at Ionizing Radiation-Induced Nuclear Foci.

In my end is my beginning: control of end resection and DSBR pathway ‘choice’ by cyclin-dependent kinases

Homologous Recombination is Independently Regulated by BRCA1 and P53

BRCA 1 and CtIP suppress long tract gene conversion

A cell cycle-dependent BRCA1–UHRF1 cascade regulates DNA double-strand break repair pathway choice

53BP1 Loss Rescues Embryonic Lethality but Not Genomic Instability of BRCA1 Total Knockout Mice

BRCA1 and CtIP suppress long-tract gene conversion between sister chromatids

A Dual Role of BRCA1 in Two Distinct Homologous Recombination Mediated Repair in Response to Replication Arrest

53bp1 Inhibits Homologous Recombination In Brca1-Deficient Cells By Blocking Resection Of Dna Breaks

Cell Cycle-dependent Complex Formation of BRCA1·CtIP·MRN is Important for DNA Double-strand Break Repair

Distinct roles of the two BRCA2 DNA binding domains in DNA damage repair and replication fork preservation

Nonhomologous End-Joining of Ionizing Radiation-Induced DNA Double-Stranded Breaks in Human Tumor Cells Deficient in BRCA1 or BRCA2.

53BP1 promotes microhomology-mediated end-joining in G1-phase cells.

BRCA1 Interaction with Non-Canonical DNA Structures: Insights into Genome Maintenance and Disease Mechanisms

Involvement of Brca1 in S-phase and G(2)-phase Checkpoints after Ionizing Irradiation.

53BP1 and BRCA1 Control Pathway Choice for Stalled Replication Restart

BRCA1: a Key Player at Multiple Stages of Homologous Recombination in DNA Double-Strand Break Repair

Deficiency of Human BRCA2 Leads to Impaired Homologous Recombination but Maintains Normal Nonhomologous End Joining

BRCA1: Cell Cycle Checkpoint, Genetic Instability, DNA Damage Response and Cancer Evolution